Andere Sprachen Sumitomo Pharma Co., Ltd.

Aktien

858257

JP3495000006

4506

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 15.05.2024			% 5 Tage	% 1. Jan.
376 ^JPY	-8,96 %		+4,44 %	-19,31 %

07.05.	Gewinnmitnahmen und China-Ausblicke belasten asiatische Aktienmärkte	MT
02.05.	Fed-Ausblick und Gewinnsaison beunruhigen asiatische Aktienmärkte	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sumitomo Pharma : May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results	14.05.
Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers	14.05.
Sumitomo Pharma : Presentation Material (Conference on FY2023 Financial Results)	14.05.
Sumitomo Pharma : Start of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate	14.05.
Sumitomo Pharma : Notice of Company Split (Simplified Absorption-type Company Split) of the Frontier Business and Notice of Business Acquisition by a Wholly-Owned Subsidiary of the Company	09.05.
Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.	09.05.
Profit-Taking, China Outlooks Churn Asian Stock Markets	07.05.
Sumitomo Pharma : Posted Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	07.05.
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript	07.05.
Fed Outlook, Earnings Season Roil Asian Stock Markets	02.05.
Sumitomo Pharma Sees Impairment Losses and Restructuring Expenses in Fiscal 2024	02.05.
Sumitomo Pharma Expects Substantial Valuation Loss on Subsidiary Shares; Assures No Impact on Consolidated Profit	02.05.
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	02.05.
Sumitomo Pharma : Presentation Material (Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024)	30.04.
Poxel : reporte la publication de ses résultats annuels 2023	29.04.
Lull in Geopolitical Tensions Lifts Asian Stock Markets	22.04.
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	02.04.
Roivant's anti-inflammatory drug succeeds in mid-stage study	02.04.
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18.03.
Sumitomo Pharma Co., Ltd.(TSE:4506) dropped from S&P Japan 500	18.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sumitomo Pharma Co., Ltd.

Aktien

858257

JP3495000006

4506

Andere Sprachen

Filter